Literature DB >> 34981707

Liver Transplant in Hemoglobin SC Disease and Autoimmune Hepatitis: A Case Report.

Ahyoung Kim1, Naziheh Assarzadegan, Robert A Anders, Kiyoko Oshima, Shruti Chaturvedi, Sharon Weeks, Ruhail Kohli, Sophie Lanzkron, Ahmet Gurakar, Jacqueline Garonzik-Wang, Po-Hung Chen.   

Abstract

Although liver transplant is a life-saving measure for individuals with end-stage liver disease, the perioperative management may be challenging in individuals with concomitant sickle cell disease. We report a case of a 50-year-old man with sickle cell disease genotype SC (HbSC) and cirrhosis secondary to autoimmune hepatitis who underwent liver transplant. His postoperative course included upper extremity deep vein thrombosis, pulmonary embolus, stroke via a patent foramen ovale after a line removal, and posterior reversible encephalopathy syndrome. Fortunately, he is alive with a functioning graft at 10 months after liver transplant. This case highlights the feasibility of liver transplant in sickle cell disease given the support of meticulous multidisciplinary care and the unique aspects of autoimmune hepatitis and sickle cell disease for liver transplant consideration.

Entities:  

Mesh:

Year:  2022        PMID: 34981707      PMCID: PMC9050897          DOI: 10.6002/ect.2021.0350

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  10 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  Autoimmune Liver Disease in Children with Sickle Cell Disease.

Authors:  Suttiruk Jitraruch; Emer Fitzpatrick; Maesha Deheragoda; Annamaria Deganello; Giorgina Mieli-Vergani; Susan Height; David Rees; Nedim Hadzic; Marianne Samyn
Journal:  J Pediatr       Date:  2017-07-20       Impact factor: 4.406

3.  Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.

Authors:  Monika Hurtova; Dora Bachir; Ketty Lee; Julien Calderaro; Thomas Decaens; Michael D Kluger; Elie Serge Zafrani; Daniel Cherqui; Ariane Mallat; Frédéric Galactéros; Christophe Duvoux
Journal:  Liver Transpl       Date:  2011-04       Impact factor: 5.799

Review 4.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

5.  Liver transplantation in patients with sickle cell disease: possible but challenging-a cohort study.

Authors:  Eric Levesque; Chetana Lim; Cyrille Feray; Chady Salloum; Anne-Laure Quere; Benoit Robin; Jean-Claude Merle; Francesco Esposito; Christophe Duvoux; Daniel Cherqui; Anoosha Habibi; Frédéric Galacteros; Pablo Bartolucci; Daniel Azoulay
Journal:  Transpl Int       Date:  2020-07-06       Impact factor: 3.782

Review 6.  Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease.

Authors:  Ziad Solh; Michael S Taccone; Samantha Marin; Uma Athale; Vicky R Breakey
Journal:  Pediatr Blood Cancer       Date:  2016-02-12       Impact factor: 3.167

7.  Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.

Authors:  Tiffany T Yu; Julie Nelson; Michael B Streiff; Sophie Lanzkron; Rakhi P Naik
Journal:  Thromb Res       Date:  2016-03-02       Impact factor: 3.944

8.  Pathological spectrum of liver diseases in sickle cell disease.

Authors:  M Omata; C S Johnson; M Tong; D Tatter
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

Review 9.  The paradox of hemoglobin SC disease.

Authors:  Ronald L Nagel; Mary E Fabry; Martin H Steinberg
Journal:  Blood Rev       Date:  2003-09       Impact factor: 8.250

10.  Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).

Authors:  Caroline Conceição da Guarda; Sètondji Cocou Modeste Alexandre Yahouédéhou; Rayra Pereira Santiago; Joelma Santana Dos Santos Neres; Camila Felix de Lima Fernandes; Milena Magalhães Aleluia; Camylla Vilas Boas Figueiredo; Luciana Magalhães Fiuza; Suellen Pinheiro Carvalho; Rodrigo Mota de Oliveira; Cleverson Alves Fonseca; Uche Samuel Ndidi; Valma Maria Lopes Nascimento; Larissa Carneiro Rocha; Marilda Souza Goncalves
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.